ImmPACT-Bio

ImmPACT-Bio is developing a strategy to differentiate cancerous from noncancerous tissues in order to improve the safety of chimeric antigen receptor T-cell (CAR-T) therapy. The company's product is designed to assure tumor specificity by inducing cytoto...